SCHEMBL23914117

SCHEMBL23914117

CC(C)(C)OC(=O)CCNC(=O)c1cc(O)c(O)c(O)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.45
LMNA P02545 2/20 0.45
POLB P06746 2/20 0.45
GAA P10253 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MAPT P10636 2/20 0.45
NSD2 O96028 1/20 0.45
ALDH1A1 P00352 1/20 0.45
ALPL P05186 1/20 0.45
ALPI P09923 1/20 0.45
ALPG P10696 1/20 0.45
APEX1 P27695 1/20 0.45
HTT P42858 1/20 0.45
RECQL P46063 1/20 0.45
BLM P54132 1/20 0.45
CASP6 P55212 1/20 0.45
SERPINE1 P05121 2/20 0.44
PRSS1 P07477 1/20 0.42
CTSG P08311 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2268285 0.81 ESRRG (0.54) GAAL3MBTL1MAPTALDH1A1BLM
SCHEMBL23914116 0.79 KMT2A (0.63) POLBSMN1; SMN2MEN1KMT2ARXFP1
SCHEMBL27453159 0.79 PRSS1 (0.69) KDM4ELMNAPOLBGAAPRSS1
SCHEMBL13605086 0.78 RAB9A (0.57) LMNAPOLBGAAL3MBTL1MAPT
SCHEMBL18897013 0.78 NPC1 (0.56) LMNAPOLBTDP1L3MBTL1ALDH1A1
SCHEMBL2644738 0.78 PRSS1 (0.50) POLBL3MBTL1MAPTALDH1A1PRSS1
SCHEMBL30910423 0.78 MEN1 (0.45) KDM4ELMNAPOLBGAATDP1
SCHEMBL13286830 0.77 KDM4E (0.65) KDM4ELMNAPOLBGAATDP1
SCHEMBL5628818 0.77 CYP1A2 (0.54) POLBGAAL3MBTL1MAPTALDH1A1
SCHEMBL8352922 0.77 L3MBTL1 (0.54) POLBL3MBTL1PRSS1CTSGCTRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239833-A1 ALKOXYPHENYL DERIVATIVES, PROTECTED NUCLEOSIDES AND PROTECTED NUCLEOTIDES, METHOD FOR PRODUCING OLIGONUCLEOTIDES, AND METHOD FOR REMOVING SUBSTITUENTS FUJIMOTO CHEMICALS CO., LTD., (JP) 2024-07-18 US disclosed
US-20210317159-A1 ALKOXYPHENYL DERIVATIVES, PROTECTED NUCLEOSIDES AND PROTECTED NUCLEOTIDES, METHOD FOR PRODUCING OLIGONUCLEOTIDES, AND METHOD FOR REMOVING SUBSTITUENTS FUJIMOTO CHEMICALS CO., LTD. (JP) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317159-A1 ALKOXYPHENYL DERIVATIVES, PROTECTED NUCLEOSIDES AND PROTECTED NUCLEOTIDES, METHOD FOR PRODUCING OLIGONUCLEOTIDES, AND METHOD FOR REMOVING SUBSTITUENTS ROS1, POLN, RNMT KDM4E 3094/4885LMNA 274/4885POLB 45/4885
US-20240239833-A1 ALKOXYPHENYL DERIVATIVES, PROTECTED NUCLEOSIDES AND PROTECTED NUCLEOTIDES, METHOD FOR PRODUCING OLIGONUCLEOTIDES, AND METHOD FOR REMOVING SUBSTITUENTS ROS1, POLN, RNMT KDM4E 3094/4885LMNA 274/4885POLB 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.